Public Profile

Theravalues

Theravalues, a prominent player in the biotechnology sector, is headquartered in Japan and operates extensively across Asia and Europe. Founded in 2015, the company has rapidly established itself as a leader in developing innovative therapeutic solutions, particularly in the fields of regenerative medicine and advanced cell therapies. Theravalues is renowned for its unique approach to harnessing the potential of stem cells, offering cutting-edge products that address critical health challenges. With a commitment to research and development, the company has achieved significant milestones, including partnerships with leading research institutions and successful clinical trials. Recognised for its contributions to the industry, Theravalues continues to push the boundaries of medical science, positioning itself as a trusted name in biotechnology and a pioneer in transformative healthcare solutions.

DitchCarbon Score

How does Theravalues's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Theravalues's score of 3 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

1%

Theravalues's reported carbon emissions

Theravalues, headquartered in Japan, currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not disclosed. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of concrete emissions data, it is essential to note that many companies in the industry are increasingly committing to sustainability and carbon neutrality. Theravalues may be aligning with these trends, but without specific commitments or targets, their current climate strategy remains unclear.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Theravalues's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Theravalues is headquartered in JP, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Theravalues is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Square Health

GB
Health Services
Updated 10 days ago

Medpeer

JP
Health Services
Updated 11 days ago
CDP

Ebos

AU
Health Services
Updated 3 days ago

Hirslanden

CH
Health Services
Updated 10 days ago

Eye Mark Ltd

GB
Health Services
Updated 10 days ago

MAXICARE

PH
Health Services
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers